Isis Pharmaceuticals News
Most Popular Isis Pharmaceuticals Story
Genzyme, Isis solidify collaboration agreement
Genzyme Corp. and Isis Pharmaceuticals Inc. completed their agreement for the cholesterol drug candidate, mipomersen. The two companies have been developing an agreement to work together and... Read more...
Latest Headlines
- June 25, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
